New mRNA vaccine aims to shield seniors from two dangerous respiratory viruses
NCT ID NCT06237296
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This early-stage study tested an experimental mRNA vaccine designed to prevent lower respiratory tract disease caused by RSV and hMPV viruses. About 558 healthy adults aged 18-49 and 60+ received a single injection at different doses. Researchers monitored safety and immune responses for up to 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Clinical Research- Site Number : 8400005
Meridian, Idaho, 83642, United States
-
Charlottesville Medical Research Center Winding River - Site Number : 8400002
Charlottesville, Virginia, 22911, United States
-
Coastal Carolina Research Center- Site Number : 8400001
North Charleston, South Carolina, 29405, United States
-
Investigational Site Number : 0360001
Camberwell, Victoria, 3124, Australia
-
Investigational Site Number : 0360002
Botany, New South Wales, 2019, Australia
-
Investigational Site Number : 0360003
Kanwal, New South Wales, 2259, Australia
-
Investigational Site Number : 0360004
Sydney, New South Wales, 2035, Australia
-
Investigational Site Number : 0360005
Morayfield, Queensland, 4506, Australia
-
Investigational Site Number : 0360006
Blacktown, New South Wales, 2148, Australia
-
Investigational Site Number : 0360007
Canberra, 2617, Australia
-
Investigational Site Number : 0360008
Herston, Queensland, 4006, Australia
-
Meridian Clinical Research- Site Number : 8400007
Binghamton, New York, 13905, United States
-
Velocity Clinical Research, Sioux City Site Number : 8400017
Sioux City, Iowa, 51106, United States
-
Velocity Clinical Research- New Orleans Site Number : 8400016
New Orleans, Louisiana, 70119, United States
-
Velocity Clinical Research- Site Number : 8400012
Cleveland, Ohio, 44122, United States
-
Velocity Clinical Research-Hallandale Beach- Site Number : 8400013
Hallandale, Florida, 33009, United States
-
Velocity Gardena Site Number : 8400011
Gardena, California, 90247, United States
Conditions
Explore the condition pages connected to this study.